The Thai Red Cross Society Prevention of Mother-To-Child Transmission of HIV (TRCS PMTCT) Program
NCT02151838 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2021-07-12
Summary
To assess the safety and the efficacy of Highly Active Anti-Retroviral Treatment (HAART) for the Prevention of Mother-To-Child Transmission of HIV (PMTCT)
Conditions
- HIV-infected Pregnant Women Who Request HAART From the TRCSPMTCT
Sponsors & Collaborators
-
Thai Red Cross AIDS Research Centre
lead OTHER
Eligibility
- Min Age
- 15 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2020-12-31
- Completion
- 2021-07-31
Countries
- Thailand
Study Locations
More Related Trials
-
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women
NCT00955968 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention
NCT03235310 ·Status: UNKNOWN
-
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
NCT00753324 ·Status: COMPLETED ·Phase: PHASE4
-
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
NCT00204308 ·Status: COMPLETED ·Phase: PHASE2
-
Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand
NCT00162682 ·Status: COMPLETED ·Phase: PHASE3
-
ARVs to Prevent Breastmilk HIV:Viral and Immune Responses
NCT00167674 ·Status: COMPLETED ·Phase: PHASE2
-
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
NCT00270296 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1
NCT06517693 ·Status: RECRUITING ·Phase: PHASE1
-
Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV
NCT00307151 ·Status: COMPLETED ·Phase: PHASE2
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
NCT02738502 ·Status: COMPLETED ·Phase: PHASE2
-
Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
NCT01933477 ·Status: COMPLETED ·Phase: NA
-
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
NCT01061151 ·Status: COMPLETED ·Phase: PHASE3
-
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
NCT00936195 ·Status: WITHDRAWN ·Phase: PHASE3
-
RH and Adolescents
NCT02713750 ·Status: COMPLETED
-
A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS)
NCT00144183 ·Status: COMPLETED ·Phase: PHASE3
-
DTG Plus 3TC for Prophylaxis of Mother-to-child Transmission of HIV Infection in Pregnant Women
NCT04808973 ·Status: COMPLETED ·Phase: PHASE3
-
Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety
NCT03519503 ·Status: COMPLETED
-
Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
NCT00386230 ·Status: COMPLETED ·Phase: PHASE3
-
Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection
NCT02166502 ·Status: COMPLETED
-
POC HIV Testing and Early DTG Use for Infants
NCT05393193 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost
NCT01645865 ·Status: COMPLETED
-
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
NCT05154513 ·Status: COMPLETED